[HTML][HTML] Standardization of the [68Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer

LL Fuscaldi, DV Sobral, ACR Durante, FF Mendonça… - Pharmaceuticals, 2021 - mdpi.com
Prostate-specific membrane antigen (PSMA) is a glycoprotein present in the prostate, that is
overexpressed in prostate cancer (PCa). Recently, PSMA-directed radiopharmaceuticals …

Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [18F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model

SB Kim, IH Song, SY Kim, HY Ko, HS Kil… - Molecular …, 2022 - ACS Publications
Several radiolabeled prostate-specific membrane antigen (PSMA)-targeted agents have
been developed for detecting prostate cancer, using positron emission tomography imaging …

[HTML][HTML] [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

U Hennrich, M Eder - Pharmaceuticals, 2021 - mdpi.com
For the positron emission tomography (PET) imaging of prostate cancer, radiotracers
targeting the prostate-specific membrane antigen (PSMA) are nowadays used in clinical …

Fine‐tuning of the automated [18F]PSMA‐1007 radiosynthesis

O Shamni, B Nebeling, H Grievink… - Journal of Labelled …, 2019 - Wiley Online Library
Radiolabeled prostate‐specific membrane antigen (PSMA) targeting PET‐tracers have
become desirable radiopharmaceuticals for the imaging of prostate cancer (PC). Recently …

Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC—a PSMA specific probe for PET imaging of prostate cancer

CH Pfob, S Ziegler, FP Graner, M Köhner… - European journal of …, 2016 - Springer
Purpose Positron emission tomography (PET) agents targeting the prostate-specific
membrane antigen (PSMA) are currently under broad clinical and scientific investigation. 68 …

Evaluation of an automated module synthesis and a sterile cold kit–based preparation of 68Ga-PSMA-11 in patients with prostate cancer

L Calderoni, A Farolfi, D Pianori, E Maietti… - Journal of Nuclear …, 2020 - Soc Nuclear Med
68Ga-labeled urea-based inhibitors of the prostate-specific membrane antigen (PSMA),
such as 68Ga-PSMA-11, are promising small molecules for targeting prostate cancer (PCa) …

Preparation of [68Ga] PSMA-11 for PET–CT imaging using a manual synthesis module and organic matrix based 68Ge/68Ga generator

R Nanabala, MK Anees, A Sasikumar, A Joy… - Nuclear medicine and …, 2016 - Elsevier
Abstract Introduction [68 Ga] PSMA-11 is a relatively recently introduced
radiopharmaceutical for PET–CT imaging of prostate cancer patients. The availability of 68 …

[HTML][HTML] Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate …

M Hohberg, C Kobe, P Krapf, P Täger, J Hammes… - EJNMMI research, 2019 - Springer
Aim We investigated the whole-body distribution and the radiation dosimetry of [18 F]-JK-
PSMA-7, a novel 18 F-labeled PSMA-ligand for PET/CT imaging of prostate cancer. Methods …

Convenient Preparation of [68Ga]DKFZ-PSMA-11 Using a Robust Single-Vial Kit and Demonstration of Its Clinical Efficacy

D Satpati, A Shinto, KK Kamaleshwaran… - Molecular imaging and …, 2016 - Springer
Abstract Purpose [68 Ga] DKFZ-PSMA-11 has proved to be an important diagnostic
radiotracer for targeting prostate-specific membrane antigen (PSMA) overexpression in both …

[HTML][HTML] 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA …

CA Umbricht, M Benešová, RM Schmid, A Türler… - EJNMMI research, 2017 - Springer
Background The targeting of the prostate-specific membrane antigen (PSMA) is of particular
interest for radiotheragnostic purposes of prostate cancer. Radiolabeled PSMA-617, a 1, 4 …